Roche Chairman: Confident To Get Financing For Genentech Buy
January 30 2009 - 2:43AM
Dow Jones News
Roche Holding AG (ROG.VX) Chairman Franz Humer said Friday the
company is confident it will have the financing available to fully
take over biotechnology company Genentech Inc. (DNA), when it will
be necessary.
Humer also said it was too early to say when the deal would be
completed.
Roche said earlier Friday it is launching a hostile bid to buy
the 44% of shares in U.S. biotechnology company Genentech Inc.
(DNA) that it doesn't already own. Roche also lowered the offer
price to $86.50 a share from its original offer price of $89 a
share.
Company Web sites: www.roche.com
www.genentech.com
-By Anita Greil, Dow Jones Newswires; +41 43 443 8044 ;
anita.greil@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front
page of today's most important business and market news, analysis
and commentary. You can use this link on the day this article is
published and the following day.